Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

• Conditions: Sarcoidosis; Pulmonary Hypertension
• Interventions: Other: Observation

• Registration Number: NCT01467791
• Lead Sponsor: University of Cincinnati

Brief Summary

Registry to follow patients with sarcoidosis associated pulmonary hypertension

Detailed Description

This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH). With this registry, the investigators will characterize the demographics, clinical course, hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated pulmonary hypertension on the United States. The investigators will also compare these features to non-US sites.

Study Timeline

• Study Start: 2011-11
• Study First Submitted: 2011-11-04
• Study First Submitted QC: 2011-11-08
• Study First Posted: 2011-11-09
• Status Verified: 2015-12
• Last Update Submitted: 2015-12-04
• Last Update Posted: 2015-12-08
• Primary Completion: 2017-01
• Study Completion: 2018-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients with sarcoidosis as defined by the ATS/WASOG statement
• Patients with pulmonary hypertension as confirmed by right heart catheterization
• Patients willing to provide written informed consent

Exclusion Criteria

• Unwillingness to provide assurance that they will complete the follow up visits for the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients	Observation	All patients with sarcoidosis associated pulmonary hypertension

Primary Outcome Measures

Name	Time	Method
Survival	4 years	Mortality during time of study

Secondary Outcome Measures

Name	Time	Method
Disease management	4 years	Examine initial and follow up management

Trial Locations

Locations (1)

University of Cincinnati; 🇺🇸 Cincinnati, Ohio, United States